EARLY BIRD DISCOUNT! Register by May 7, 2014 to receive 20% off your registration!
Register 3 for the price of 2 with the coupon code rcdvb!

 Overview | Speakers | Agenda | Poster Submissions | Venue | Sponsors
Dear Colleague,

We welcome you to GTC's Novel Cancer Therapeutics Summit 2014 taking place on July 7-8, 2014 in Boston, MA. This summit includes two parallel conferences focused on both the research, and business perspectives in oncology.

This summit will continue to be a premier event for translational researchers, preclinical scientists and managers, and those carrying out early phase clinical trials, working to identify and exploit advances in the field in order to deliver products with a meaningful clinical impact. Areas of discussion include cancer biomarkers, emerging targets, therapeutic strategies, progress in cancer immunotherapy, and combination strategies in immuno-oncology.  Both cutting-edge researchers and those who guide its commercial development will be on-hand to share their knowledge and insights as to how therapeutic cancer targets are identified, and how this research translates into meaningful therapeutics that benefit patients living with cancer.

I
n addition, business development trends, markets, partnership opportunities, value maximization vs. capital efficiency, and the return of biotech IPOs will be discussed.  Come join us to network with high-level executives from top pharma and various biotech/pharmaceutical companies to explore potential collaborations and learn about relevant issues in oncology that will affect the industry!


The Novel Cancer Therapeutics Summit 2014
, includes two parallel conferences:
 

Conference A:  5th Cancer Targets & Therapeutics

I. Emerging Cancer Targets & Therapeutic Strategies
       - Kinase Inhibitors 
       - Epigenetic Regulators 
       - Metabolic Pathways 
       - Cancer Stem Cells 
II. Cancer Biomarkers in Discovery & Clinical Trials 
III. Progress in Cancer Immunotherapy
IV. Combination Strategies in Immuno-Oncology 


Conference B:  3rd Oncology Partnering & Deal-Making

I. Investments, Partnerships & Acquisitions: Trends & Recent Deals
II. Innovative Partnering & Deal-Making (Panel Discussion)
III. IPO: The Rebirth of Access To Public Capital
IV. Value Maximization vs. Capital Efficiency (Panel Discussion)
V. Advances & Technologies in Oncology
VI. Novel Players in Oncology


Sign up
for the Summit Pass to have access to both conferences of the summit!

Sponsorship and exhibiting opportunities are available in a range of levels, which can be tailored to fit your needs. Please contact 626-256-6405x110 or 
amber.kempf@gtcbio.com for more info.




Best Regards,

Organizing Committee


2013 SPONSORS
2013 MEDIA PARTNERS
Attend ALL GTC Conferences for One Year for only $3,995 ($1,990 for Acad/Govt).
Click here to sign up!